Investing For Life: Meeting poor people’s needs for access to medicines through responsible business practices
There are major shortcomings in the pharmaceutical industry’s current initiatives to ensure that poor people have access to medicines. To shore up its own flagging economic performance, the industry is increasingly looking to the potentially huge markets within emerging economies. Yet, poor people who live in these countries still desperately lack affordable and appropriate medicines. The time is ripe for a bold new approach. The industry must put access to medicines at the heart of its decision-making and practices. This is both a more sustainable long-term business strategy and would allow the industry to better play its role in achieving the universal right to health.
How to cite this resource
Citation styles vary so we recommend you check what is appropriate for your context. You may choose to cite Oxfam resources as follows:
Author(s)/Editor(s). (Year of publication). Title and sub-title. Place of publication: name of publisher. DOI (where available). URL
Our FAQs page has some examples of this approach.